Publications
Making life better with multiplex molecular diagnostics at the Point of Care
Develop your knowledge on Q-POC solutions with scientific material – including posters, evaluations, publications – from healthcare professionals and QuantuMDx staff.
The QuantuMDx Q-POC SARS CoV-2 RT-PCR assay for rapid Detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology
Microfluidic Capture of Mycobacterium tuberculosis from Clinical Samples for Culture-Free Whole-Genome Sequencing
A Novel Microfluidic Dielectrophoresis Technology to Enable Rapid Diagnosis of Mycobacteria tuberculosis in Clinical Samples
Utilising CAPTURE-XT®, a rapid pathogen concentration and sample clean-up technology, as a front-end for Next-Generation Sequencing of Mycobacterium tuberculosis from clinical sputum samples
The aim of this project was to explore the application of CAPTURE-XT®, a microfluidic lab-on-chip pathogen concentration system which utilizes dielectrophoresis to selectively capture and concentrate whole MTB cells from sputum, as a potential front-end for NGS.
Robust detection of SARS-CoV-2 in a multi-centre evaluation of clinical performance using the QuantuMDx SARS-CoV-2 RT-PCR Detection Assay
The QuantuMDx SARS-CoV-2 RT-PCR Detection Assay has demonstrated excellent clinical performance across 5 external validation sites with positive and negative percent agreement of 99.0% and 100% respectively.
A rapid extraction-free methodology for detection of SARS-CoV-2 using the QuantuMDx SARS-CoV-2 RT-PCR Detection Assay for use in the screening of single/pooled saliva samples
QuantuMDx have optimized a methodology for detecting SARS-CoV-2 in saliva specimens without the need for extraction/swabs using commercially available SARS-CoV-2 RT-PCR Detection Assay product. The methodology cuts the time to result to <125 minutes…